5-MeO-DALT

From Wikipedia, the free encyclopedia
Jump to: navigation, search
5-MeO-DALT
5-MeO-DALT.svg
Systematic (IUPAC) name
N-allyl-N-[2-(5-methoxy
-1H-indol-3-yl)ethyl]
prop-2-en-1-amine
Identifiers
CAS Registry Number 928822-98-4 N
PubChem CID: 50878551
ChemSpider 21106245 YesY
Chemical data
Formula C17H22N2O
Molecular mass 270.375 g/mol
 N (what is this?)  (verify)

5-MeO-DALT or N,N-diallyl-5-methoxytryptamine is a psychedelic tryptamine first synthesized by Alexander Shulgin.

Chemistry[edit]

The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is chemically related to the compounds 5-MeO-DPT and DALT.

History[edit]

The first material regarding the synthesis and effects of 5-MeO-DALT was sent from Alexander Shulgin to a researcher in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet research chemical vendors. In August 2004 the synthesis and effects of 5-MeO-DALT were published by Erowid.[1]

Dosage[edit]

Doses ranging from 12–20 mg were tested by Alexander Shulgin's research group.[2]

Dangers[edit]

There are numerous anecdotal reports of users consuming dosages far in excess of those tested by Alexander Shulgin,[citation needed] although there is no published literature on the toxicity of 5-MeO-DALT.

Legal Satus[edit]

Japan[edit]

5-MeO-DALT became a controlled substance in Japan from April 2007, by amendment to the Pharmaceutical Affairs Law.[3]

United Kingdom[edit]

5-MeO-DALT became a Class A drug in the UK on January 7th 2015 after an update to the tryptamine blanket ban.

Singapore[edit]

5-MeO-DALT is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[4]

Sweden[edit]

Sveriges riksdag added 5-MeO-DALT to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of May 1, 2012, published by Medical Products Agency in their regulation LVFS 2012:6 listed as 5-MeO-DALT N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin.[5]

United States[edit]

5-MeO-DALT is not scheduled at the federal level in the United States,[6] but it is likely that it could be considered an analog of 5-Meo-DiPT or another tryptamine, in which case purchase, sale, or possession could be prosecuted under the Federal Analog Act.

Florida[edit]

5-MeO-DALT is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in Florida.[7]

Louisiana[edit]

5-MeO-DALT is a Schedule I controlled substance in the state of Louisiana making it illegal to buy, sell, or possess in Louisiana. [8]

Notes[edit]

  1. ^ [1], Morris, H. (11 May 2010). "The Last Interview With Alexander Shulgin". Vice Magazine. Retrieved 2011-02-24.
  2. ^ [2]
  3. ^ "厚生労働省:平成18年度無承認無許可医薬品等買上調査の結果について". Retrieved 2012-06-26.  (Japanese)
  4. ^ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 24 July 2015. 
  5. ^ http://www.lakemedelsverket.se/upload/lvfs/LVFS_2012_6.pdf
  6. ^ §1308.11 Schedule I.
  7. ^ Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL
  8. ^ [3]

External links[edit]